Release Date: 03/07/23 08:14 Summary: Final Distribution Announcement Price Sensitive: Yes Download Document 225.11KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%